Evidence map›Paper›PMID 33637890›Full record

ArticleEuropean journal of human genetics : EJHG2021

Genetic correlations between traits associated with hyperuricemia, gout, and comorbidities.

Richard J Reynolds, M Ryan Irvin, S Louis Bridges, Hwasoon Kim, Tony R Merriman, Donna K Arnett, Jasvinder A Singh, Nicholas A Sumpter, Alexa S Lupi, Ana I Vazquez

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Exopolysaccharides fromFoods (Basel, Switzerland) · 2026
    Article
  3. [Prognostic nutritional index and risk of incident hyperuricemia: A retrospective cohort study].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. SGLT2 Inhibitors and Uric Acid Homeostasis.Gout, urate, and crystal deposition disease · 2024
    Article
  9. The Role of Uric Acid in Human Health: Insights from theJournal of personalized medicine · 2023
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Richard J ReynoldsDepartment of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham (UAB), Birmingham, AL, USA. richardreynolds@uabmc.edu.ORCID 0000-0001-6419-7779
M Ryan IrvinDepartment of Epidemiology, UAB, Birmingham, AL, USA.
S Louis BridgesDepartment of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham (UAB), Birmingham, AL, USA.
Hwasoon KimDuke Clinical Research Institute, Durham, NC, USA.ORCID 0000-0002-0561-3186
Tony R MerrimanDepartment of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham (UAB), Birmingham, AL, USA.ORCID 0000-0003-0844-8726
Donna K ArnettCollege of Public Health, University of Kentucky, Lexington, KY, USA.ORCID 0000-0003-2219-657X
Jasvinder A SinghDepartment of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham (UAB), Birmingham, AL, USA.
Nicholas A SumpterDepartment of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham (UAB), Birmingham, AL, USA.
Alexa S LupiInstitute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, USA.
Ana I VazquezInstitute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, MI, USA. avazquez@msu.edu.ORCID 0000-0001-6618-7486
University of Alabama at Birmingham · USClinical Research Institute · USMichigan State University · USQuantitative BioSciences · USUniversity of Alabama at Birmingham Hospital · USUniversity of Kentucky · US

Funding

University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARBARA A GOWER · 2013 to 2026
$19.5M
HYPERGEN: GENETICS OF LEFT VENTRICULAR HYPERTROPHYR01HL055673 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ARNETT, DONNA K · 1996 to 2016
$18.1M
The Effects of Urate Lowering Therapy on Inflammation, Endothelial function, andP50AR060772 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SINGH, JASVINDER A · 2012 to 2021
$12.8M
Training Interventions and Genetics of Exercise Response (TIGER)R01DK062148 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BRAY, MOLLY · 2003 to 2014
$6.0M
The Family Blood Pressure Program (Program Data Center)U01HL054473 · NHLBI · WASHINGTON UNIVERSITY · PI RAO, DABEERU C · 2000 to 2008
$5.8M
Statistical Tools for Whole-Genome Prediction of Complex Traits and DiseasesR01GM101219 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DE LOS CAMPOS, GUSTAVO · 2012 to 2017
$1.6M
HYPERGEN - BIRMINGHAM FIELD CENTERU01HL054495 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LEWIS, CORA E · 2000 to 2004
$923k
HYPERGEN CENTRAL BIOCHEMISTRY LABORATORYU01HL054472 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ECKFELDT, JOHN H · 2000 to 2004
$879k
SLEEP AND ENTRAINMENT OF SCN FUNCTIONR01HL064278 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI STROHL, KINGMAN PERKINS · 1999 to 2002
$871k
Discovering Novel Genetic and Environmental Risk Factors for RA in African AmericK01AR060848 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI REYNOLDS, RICHARD JAMES · 2011 to 2015
$641k
HYPERGEN-NCU01HL054509 · NHLBI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI NORTH, KARI E · 2000 to 2004
$640k
THE FRAMINGHAM HEART STUDY-N01HC25195-268025195-268025195N01HC025195 · HC · TRUSTEES OF BOSTON UNIVERSITY · PI WOLF, PHILIP A · 2002 to 2006
–
NHLBI NIH HHS HHSN268201500001CNHLBI NIH HHS HHSN268201500001INHLBI NIH HHS N01 HC025195NHLBI NIH HHS N02 HL064278NHLBI NIH HHS R01 HL055673NHLBI NIH HHS U01 HL054472NHLBI NIH HHS U01 HL054473NHLBI NIH HHS U01 HL054495NHLBI NIH HHS U01 HL054509NIAMS NIH HHS K01 AR060848NIAMS NIH HHS P50 AR060772NIDDK NIH HHS P30 DK079626NIDDK NIH HHS R01 DK062148NIGMS NIH HHS R01 GM101219
6 · The paper itself

Abstract

Hypertension, obesity, chronic kidney disease and type 2 diabetes are comorbidities that have very high prevalence among persons with hyperuricemia (serum urate > 6.8 mg/dL) and gout. Here we use multivariate genetic models to test the hypothesis that the co-association of traits representing hyperuricemia and its comorbidities is genetically based. Using Bayesian whole-genome regression models, we estimated the genetic marker-based variance and the covariance between serum urate, serum creatinine, systolic blood pressure (SBP), blood glucose and body mass index (BMI) from two independent family-based studies: The Framingham Heart Study-FHS and the Hypertension Genetic Epidemiology Network study-HyperGEN. The main genetic findings that replicated in both FHS and HyperGEN, were (1) creatinine was genetically correlated only with urate and (2) BMI was genetically correlated with urate, SBP, and glucose. The environmental covariance among the traits was generally highest for trait pairs involving BMI. The genetic overlap of traits representing the comorbidities of hyperuricemia and gout appears to cluster in two separate axes of genetic covariance. Because creatinine is genetically correlated with urate but not with metabolic traits, this suggests there is one genetic module of shared loci associated with hyperuricemia and chronic kidney disease. Another module of shared loci may account for the association of hyperuricemia and metabolic syndrome. This study provides a clear quantitative genetic basis for the clustering of comorbidities with hyperuricemia.

Indexed as

Cardiometabolic Risk FactorsQuantitative Trait LociBayes TheoremBlood PressureComorbidityCreatinineGenome-Wide Association StudyGoutHumansHyperuricemiaUric AcidCreatinineUric Acid

Identifiers

PMID33637890
PMCPMC8440599
OpenAlexW3129769933

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.